Hellenic Neuro-Οncology Society

Hellenic Neuro-oncology Society

Neurosurgery Clinic , General Hospital "Evangelismos" - University of Athens

INTRODUCTION

Worldwide, patients with tumors of the central nervous system are treated initially by groups of Physicians of different specialties (MDT – Multi-Disciplinary Team), which are responsible for their management from the beginning (diagnosis) to the end (treatment and rehabilitation ).

The University Neurosurgery Clinic of Evangelismos Public Hospital has a long history in the treatment of CNS tumors, with more than five thousand cases over the last 60 years. Taking advantage of this experience we proceeded to create a modern Neuro-oncology team composed of doctors from different disciplines with a common object: tumors of the Central Nervous System. The selection criteria of the members for the team staffing was based on their scientific background and their experience in the field of CNS tumors.

Scientific partners and specialized physicians of all these disciplines analyze each newly diagnosed case, progressing in defining, planning and conducting the necessary laboratory tests to identify the tumor (site, size, histological and molecular profile). Then based on data obtained for each patient, they plan and propose, tailoring the best combination treatment (surgery, radiotherapy, radiosurgery, chemotherapy). Finally they monitor patients with clinical-laboratory tests, record their progress and support their recovery.

The Neuro-Oncology group we set up, is composed of doctors from different healthcare facilities (university hospitals, general hospitals, Public Health System and military medical units), who -having completed the part of basic studies of their specialties- were trained in international hospitals and universities in the object of CNS tumors.

The excellent cooperation between team members, the integrity of their knowledge as a result of their expertise in the subject, and finally the scientific collaboration with European Neuro-Oncology groups, are the basis for ensuring the most modern and effective management of patients with CNS tumors in Greece .

The research part of the team is in constant evolution, with numerous papers in scientific conferences and publications in scientific journals. Research for diagnosis and treatment protocols is in progress, while new guidelines are planned and discussed by members of the group, in order to improve the therapeutic effect, as well as the quality of the patient’s life.

Neuro-Oncology
News and Research

New recommendations for diagnosis and treatment of brain metastases from solid tumors
09 Aug 2021

Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two of the largest international oncology societies have published new clinical guidelines for the diagnosis and treatment of brain metastases from solid tumors.

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients
27 Jul 2021

Gateway for Cancer Research℠ awards grant to the EORTC 1634- Brain Tumour Group (BTG) academic trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I).

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients
18 Jun 2021

KIYATEC, Inc. announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM) and other high-grade glioma (HGG) patients.

NFCR announces winners of 2021 Salisbury Award Competition
26 May 2021

The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.

Using ultrasound and RNA-loaded nanoparticles to deliver potent medicine to brain tumors
07 May 2021

RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and able to go where no drug has gone before, reaching previously undruggable pathways.

Research finds possible explanation for why many cancer drugs don't work in human trials
01 Apr 2021

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won't work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.

Giving chemotherapy in the morning can extend survival of glioblastoma patients
31 Mar 2021

An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years.

Dexamethasone use could reduce immune checkpoint inhibitor efficacy in glioblastoma patientsScientists discover new immunotherapy target for malignant brain tumors
15 Feb 2021

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body's immune system.

MSK researchers report an underlying cause of COVID brain
09 Feb 2021

One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition that's informally called "COVID brain" or "brain fog."

RENACER: New national hospital network aims to advance research on brain metastases
27 Jan 2021

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1
15 Jan 2021

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children's Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

Scientific Fields of Neuro-oncology

Neurosurgery

ΑΚΤΙΝΟΘΕΡΑΠΕΙΑ-ΚΟΥΜΠΙ

Radiotherapy

SRS-ΚΟΥΜΠΙ

Stereotactic Radiosurgery

chemotherapy2

Chemotherapy

ΝΕΥΡΟΑΠΕΙΚΟΝΙΣΗ-ΚΟΥΜΠΙ

Neuro-imaging

ΝΕΥΡΟΨΥΧΟΛΟΓΙΑ-ΚΟΥΜΠΙ-2

Neuropsycology

ΝΕΥΡΟ-ΠΑΘΟΛΟΓΟΑΝΑΤΟΜΙΑ-ΚΟΥΜΠΙ

Neuro-pathology

ΝΕΥΡΟ-ΑΝΑΙΣΘΗΣΙΑ-ΚΟΥΜΠΙ

Neuro-anesthesia

ΑΠΟΚΑΤΑΣΤΑΣΗ-ΚΟΥΜΠΙ

Rehabilitation

Events and Newsroom

coming soon

➦ NEWSROOM

Frequently asked questions considering brain and spinal neoplasms

Glioblastoma

GBM for RT (fig2)

Meningioma

meningioma pic1

Astrocytoma

ASTRO III b

Upcoming Congresses, Seminars and Meetings regarding Neuro-oncology

More on Neuro-oncology

photo-900x423
Introducing
Protontherapy
logo-srs-neuro
Introducing
Radiosurgery Group – Hellenic Neurooncology Society
second opinion1
Ask for a "Second opinion" from the doctors of the "Hellenic Neuro-oncology Society"
ENXA_BANNER_2

University of Athens
Experimental Laboratory Neurosurgery Anatomy

survivor_new
Neuro-Psychology

Patients with brain tumors after completion of multimodality treatment need psychology support and regular follow up. Ask for an appointment with our Neuro-psychologist..
ribbon_brain
Grey awareness ribbon

Grey ribbon is a symbol of brain tumor.

Useful Links

European Society for Radiotherapy & Oncology
American Society for Radiation Oncology
The Congress of Neurological Surgeons
American Association of Neurological Surgeons
Ελληνική Νευροχειρουργική Εταιρεία
European Association of Neuro-Oncology
European Association of Neurosurgical Societies
European Organisation for Research and Treatment of Cancer
International Stereotactic Radiosurgery Society

You will find us

© Copyright 2016-2021 - neurooncology.gr - HeNOG - All Rights Reserved